Effect of a peroxisome proliferator-activated receptor-gamma agonist on myocardial blood flow in type 2 diabetes - Test2 - elhamkhani - TriplyDB

Effect of a peroxisome proliferator-activated receptor-gamma agonist on myocardial blood flow in type 2 diabetes

Effect of a peroxisome proliferator-activated receptor-gamma agonist on myocardial blood flow in type 2 diabetes

http://www.wikidata.org/entity/Q34509903

about

Myocardial blood flow under general anaesthesia with sevoflurane in type 2 diabetic patients: a pilot study.Pioglitazone and cardiovascular risk. A comprehensive meta-analysis of randomized clinical trials.PPARδ activation protects endothelial function in diabetic mice.The influence of insulin resistance, obesity, and diabetes mellitus on vascular tone and myocardial blood flow.Relationship between glycosylated hemoglobin A1c and coronary flow reserve in patients with Type 2 diabetes mellitus.Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus.A meta-analysis of the effect of thiazolidinediones on blood pressure.

P2860

Q30439771-7727C684-C059-4FB4-9254-B4210F1E4B6F Q34781949-76F934E2-D532-456A-B9D7-200370A7749B Q36410664-D528B96D-D7B8-44C2-B3F6-260B092DF556 Q37972078-64B29612-1F8F-44F0-931F-E73F9EC79E1B Q38361356-A86DA485-A683-49C8-A189-7CD2FDBB11A2 Q46874592-BFFD05AE-64AE-4A3B-8EE9-662DA94A196F Q46890745-E232F2FA-4EEC-4848-A82C-E1C93FDC9FA3

P2860

Effect of a peroxisome proliferator-activated receptor-gamma agonist on myocardial blood flow in type 2 diabetes

http://www.wikidata.org/entity/Q34509903

description

2005 nî lūn-bûn

@nan

2005 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Effect of a peroxisome prolife ...... blood flow in type 2 diabetes

@ast

Effect of a peroxisome prolife ...... blood flow in type 2 diabetes

@en

Effect of a peroxisome prolife ...... blood flow in type 2 diabetes

@nl

type

label

Effect of a peroxisome prolife ...... blood flow in type 2 diabetes

@ast

Effect of a peroxisome prolife ...... blood flow in type 2 diabetes

@en

Effect of a peroxisome prolife ...... blood flow in type 2 diabetes

@nl

prefLabel

Effect of a peroxisome prolife ...... blood flow in type 2 diabetes

@ast

Effect of a peroxisome prolife ...... blood flow in type 2 diabetes

@en

Effect of a peroxisome prolife ...... blood flow in type 2 diabetes

@nl

P1433

Q34509903-E8999A7C-8B49-4E5F-A2A5-AA2F0ED93ADF

P1476

Q34509903-D619FE14-E109-4696-A233-C5C055FDC43C

P2093

Q34509903-22186582-AAE4-463B-BD24-F59AD8DC3742

Q34509903-992D3181-B402-42F2-8500-C87D7445AB78

Q34509903-F1E9D65D-A928-4F49-9FFE-176532B88F5C

Q34509903-F315CD7D-EE57-49A9-95B8-D014367EF259

Q34509903-F935C58F-BBC8-4096-A0B3-B97C0A1EB3E1

P2860

Q34509903-03F27BD3-BF08-439B-A948-43DF6D28BAD0

Q34509903-0C8E41F6-713A-4C86-B446-6D712FB4444B

Q34509903-150903D4-98C0-4008-96A9-6EA5F4C68D71

Q34509903-15C1AEBA-1D4E-4105-BF70-F62FE94D50F8

Q34509903-165B9CF0-78DB-48F2-9AD5-88077C10D93B

Q34509903-25B35AB5-A9BD-4453-98CC-5D30DD22A581

Q34509903-26F32E52-9ADA-4503-9A0E-42CABBB4A342

Q34509903-2E5522DB-2366-486B-8336-B91FC39CDDBB

Q34509903-4C5474E8-2D54-4FBD-985F-C30C5A94D1FA

Q34509903-599EB0E6-D6DC-43D4-A49F-67A74CCAC049

P304

Q34509903-4513C30C-4A25-4D0E-9D63-EA0BB255150E

P31

Q34509903-A665C513-635C-44E2-A7AB-028E3D3A24F4

P356

Q34509903-32D773C1-C499-45C6-8053-A687DBBBB1CC

P407

Q34509903-97687604-B75E-44CA-B4FC-C483FF679106

P433

Q34509903-DC6ABA23-553B-4545-8B92-421ECD81B1CA

P478

Q34509903-7ECA4990-12DD-482A-8EE6-654F029721CE

P50

Q34509903-F4820A6D-EAAC-4447-8436-8DA96F241678

P577

Q34509903-09212D3F-8C95-4011-B631-A7F21AA42665

P5875

Q34509903-BADCBCB7-C062-4E00-ADD0-F5C04FFFC3F2

P698

Q34509903-6C9795D0-5837-42A4-AF48-75010935EE26

P921

Q34509903-8EFDA7B5-D072-4B6B-8744-0ED3CB9041E0

P932

Q34509903-A8B088DC-0793-46C1-BB72-1F81C657F56A

P356

DIACARE.28.5.1145

P1433

P1476

Effect of a peroxisome prolife ...... blood flow in type 2 diabetes

@en

P2093

Edouard Daher

http://www.w3.org/2001/XMLSchema#string

George Grunberger

http://www.w3.org/2001/XMLSchema#string

Jorge Plutzky

http://www.w3.org/2001/XMLSchema#string

Marcelo F DiCarli

http://www.w3.org/2001/XMLSchema#string

Tammy Bhattacharyya

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction

Rosiglitazone treatment increases nitric oxide production in human peripheral skin: a controlled clinical trial in patients with type 2 diabetes mellitus.

The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial.

Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice.

Suppression of nuclear factor-kappaB and stimulation of inhibitor kappaB by troglitazone: evidence for an anti-inflammatory effect and a potential antiatherosclerotic effect in the obese.

Peroxisome proliferator-activated receptors in endothelial cell biology.

Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor.

Nitric oxide release accounts for insulin's vascular effects in humans.

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.

Expression and function of PPARgamma in rat and human vascular smooth muscle cells.

P304

1145-1150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DIACARE.28.5.1145

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Graham T. McMahon

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7881652

http://www.w3.org/2001/XMLSchema#string

P698

15855580

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

4231709

http://www.w3.org/2001/XMLSchema#string